Related references
Note: Only part of the references are listed.Molecular characterization of carbapenem-resistant Enterobacteriaceae and emergence of tigecycline non-susceptible strains in the Henan province in China: a multicentrer study
Wen Juan Yan et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2021)
Characterization of Salmonella enterica Isolates from Selected US Swine Feed Mills by Whole-Genome Sequencing
Valentina Trinetta et al.
FOODBORNE PATHOGENS AND DISEASE (2020)
Resistance to ceftazidime-avibactam and underlying mechanisms
Yuhang Wang et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Outbreak of KPC-2-Producing Klebsiella pneumoniae ST76 Isolates in an Intensive Care Unit and Neurosurgery Unit
Shanshan Su et al.
MICROBIAL DRUG RESISTANCE (2020)
The Bacteria Genome Pipeline (BAGEP): an automated, scalable workflow for bacteria genomes with Snakemake
Idowu B. Olawoye et al.
PEERJ (2020)
Prevalence, risk factors and molecular epidemiology of carbapenem-resistantKlebsiella pneumoniaein patients from Zhejiang, China, 2008-2018
Yanyan Hu et al.
EMERGING MICROBES & INFECTIONS (2020)
Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam
I. Galani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates
Michael Feldgarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae
William R. Wilson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa
Dandan Yin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
An integrated quantitative proteomic and metabolomics approach to reveal the negative regulation mechanism of LamB in antibiotics resistance
Wanxin Li et al.
JOURNAL OF PROTEOMICS (2019)
Haemophilus parasuis VtaA2 is involved in adhesion to extracellular proteins
Mar Costa-Hurtado et al.
VETERINARY RESEARCH (2019)
Treatment of Infections Due to MDR Gram-Negative Bacteria
Matteo Bassetti et al.
FRONTIERS IN MEDICINE (2019)
Hospital Outbreak of a Colistin-Resistant, NDM-1-and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance
Huseyin Guducuoglu et al.
MICROBIAL DRUG RESISTANCE (2018)
Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55
Tiantian Liu et al.
VACCINE (2018)
Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai
Dongxing Tian et al.
INFECTION AND DRUG RESISTANCE (2018)
Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
Marla J. Giddins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
Liangfei Xu et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
Kirk Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested In Vitro with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam
Yunliang Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria
Abdelhamid Asli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients
Robert K. Flamm et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
In Vitro Selection of Ceftazidime-Avibactam Resistance in Enterobacteriaceae with KPC-3 Carbapenemase
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV beta-lactamases with single amino acid substitutions in the Omega-loop
Marisa L. Winkler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
Richard A. Alm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013
S. Pollett et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Decreased expression of LamB and Odp1 complex is crucial for antibiotic resistance in Escherichia coli
Xiang-min Lin et al.
JOURNAL OF PROTEOMICS (2014)
wzi Gene Sequencing, a Rapid Method for Determination of Capsular Type for Klebsiella Strains
Sylvain Brisse et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Differential regulation of OmpC and OmpF by AtpB in Escherichia coli exposed to nalidixic acid and chlortetracycline
Xiangmin Lin et al.
JOURNAL OF PROTEOMICS (2012)
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Patrice Nordmann et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases
P. R. S. Lagace-Wiens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Erik Gullberg et al.
PLOS PATHOGENS (2011)
In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Lipid domains in bacterial membranes and the action of antimicrobial agents
Richard M. Epand et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Protein complexes of the Escherichia coli cell envelope
F Stenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
